# Lookup for R5V20252ForR4 - Extensions for Using Data Elements from FHIR R5 in FHIR R4 v0.0.1-snapshot-3

## Lookup for R5V20252ForR4

### Lookup for FHIR R5 ValueSet Hl7VSCausalityObservations:http://terminology.hl7.org/ValueSet/v2-0252 for use in FHIR R4

The FHIR R5 ValueSet Hl7VSCausalityObservations has no mapping to FHIR R4.

| | | | | | | |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| `http://terminology.hl7.org/CodeSystem/v2-0252` | `AW` | Abatement of event after product withdrawn | Yes |   |   |   |
| `http://terminology.hl7.org/CodeSystem/v2-0252` | `BE` | Event recurred after product reintroduced | Yes |   |   |   |
| `http://terminology.hl7.org/CodeSystem/v2-0252` | `DR` | Dose response observed | Yes |   |   |   |
| `http://terminology.hl7.org/CodeSystem/v2-0252` | `EX` | Alternative explanations for the event available | Yes |   |   |   |
| `http://terminology.hl7.org/CodeSystem/v2-0252` | `IN` | Event occurred after product introduced | Yes |   |   |   |
| `http://terminology.hl7.org/CodeSystem/v2-0252` | `LI` | Literature reports association of product with event | Yes |   |   |   |
| `http://terminology.hl7.org/CodeSystem/v2-0252` | `OE` | Occurrence of event was confirmed by objective evidence | Yes |   |   |   |
| `http://terminology.hl7.org/CodeSystem/v2-0252` | `OT` | Other | Yes |   |   |   |
| `http://terminology.hl7.org/CodeSystem/v2-0252` | `PL` | Effect observed when patient receives placebo | Yes |   |   |   |
| `http://terminology.hl7.org/CodeSystem/v2-0252` | `SE` | Similar events in past for this patient | Yes |   |   |   |
| `http://terminology.hl7.org/CodeSystem/v2-0252` | `TC` | Toxic levels of product documented in blood or body fluids | Yes |   |   |   |

